Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-19-007865)

Filing Details

Accession Number:: 0001127602-19-007865
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-25 09:36:13
Reporting Period:: 2015-02-10

Accepted Time:: 2019-02-25 09:36:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614529	E Dwight Ellingwood	3471 River Hills Drive Cincinnati OH 45244		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-10	33	$18.20	3,013	No	4	P	Direct
Common Stock	Acquisiton	2015-05-11	32	$18.51	3,045	No	4	P	Direct
Common Stock	Acquisiton	2015-08-10	32	$18.69	3,077	No	4	P	Direct
Common Stock	Acquisiton	2015-11-23	32	$19.27	3,109	No	4	P	Direct
Common Stock	Acquisiton	2016-02-12	32	$19.62	3,141	No	4	P	Direct
Common Stock	Acquisiton	2016-05-16	33	$19.06	3,174	No	4	P	Direct
Common Stock	Acquisiton	2016-08-15	32	$19.50	6,206	No	4	P	Direct
Common Stock	Acquisiton	2016-11-28	38	$17.07	6,244	No	4	P	Direct
Common Stock	Acquisiton	2017-02-13	41	$12.93	7,305	No	4	P	Direct
Common Stock	Acquisiton	2017-05-15	36	$14.90	7,341	No	4	P	Direct
Common Stock	Acquisiton	2017-08-14	39	$13.94	7,380	No	4	P	Direct
Common Stock	Acquisiton	2017-11-28	38	$14.56	7,418	No	4	P	Direct
Common Stock	Acquisiton	2018-02-13	39	$14.13	7,457	No	4	P	Direct
Common Stock	Acquisiton	2018-05-15	40	$13.88	7,497	No	4	P	Direct
Common Stock	Acquisiton	2018-08-16	38	$14.91	7,535	No	4	P	Direct
Common Stock	Acquisiton	2018-11-28	31	$18.42	8,566	No	4	P	Direct
Common Stock	Disposition	2019-02-21	981	$0.00	0	No	4	J	Direct
Common Stock	Acquisiton	2019-02-21	981	$0.00	9,547	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	J	Direct
No	4	J	Direct

Footnotes

Share purchases reflected on this Form were acquired via a Dividend Reinvestment Plan ("DRIP") beginning in February 2015 and ceasing in November 2018.
Following the January 24, 2019 grant of 981 restricted stock units (as reported on Form 4 filed January 28, 2019), Common Stock holdings currently total 9,547.